Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Payables (2020 - 2025)

Bio Essence (BIOE) has 6 years of Payables data on record, last reported at $10608.0 in Q3 2025.

  • For Q3 2025, Payables fell 66.96% year-over-year to $10608.0; the TTM value through Sep 2025 reached $10608.0, down 66.96%, while the annual FY2024 figure was $17738.0, 18.96% down from the prior year.
  • Payables reached $10608.0 in Q3 2025 per BIOE's latest filing, down from $344291.0 in the prior quarter.
  • Across five years, Payables topped out at $346833.0 in Q1 2025 and bottomed at $10608.0 in Q3 2025.
  • Average Payables over 5 years is $128796.2, with a median of $86220.0 recorded in 2021.
  • The widest YoY moves for Payables: up 23393.19% in 2021, down 85.54% in 2021.
  • A 5-year view of Payables shows it stood at $60873.0 in 2021, then grew by 25.97% to $76680.0 in 2022, then crashed by 71.45% to $21889.0 in 2023, then dropped by 18.96% to $17738.0 in 2024, then tumbled by 40.2% to $10608.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $10608.0 in Q3 2025, $344291.0 in Q2 2025, and $346833.0 in Q1 2025.